Author:
Kawama Kentaro,Warabi Yoko,Bokuda Kota,Kimura Hideki,Takahashi Kazushi
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Myasthenia gravis;Gilhus NE;Nat Rev Dis Primers,2019
2. Current treatment of myasthenia gravis;Alhaidar MK;J Clin Med,2022
3. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial;Howard JF Jr;Lancet Neurol,2021
4. Efgartigimod: first approval;Heo YA;Drugs,2022
5. Myasthenia gravis exacerbation in association with antibody overshoot following plasmapheresis;Ching J;Muscle Nerve,2021